Literature DB >> 32073379

Reducing Unnecessary Biopsy and Follow-up of Benign Cystic Breast Lesions.

Wendie A Berg1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32073379      PMCID： PMC7104697          DOI： 10.1148/radiol.2020200037

Source DB:  PubMed          Journal:  Radiology        ISSN： 0033-8419            Impact factor:   11.105


× No keyword cloud information.
  9 in total

1.  Reassessment and Follow-Up Results of BI-RADS Category 3 Lesions Detected on Screening Breast Ultrasound.

Authors:  Eun Young Chae; Joo Hee Cha; Hee Jung Shin; Woo Jung Choi; Hak Hee Kim
Journal:  AJR Am J Roentgenol       Date:  2016-03       Impact factor: 3.959

2.  Which patients require or can skip biopsy for breast clustered microcysts? Predictive findings of breast cancer and mucocele-like tumor.

Authors:  Akie Tanaka; Aya Imai; Mariko Goto; Eiichi Konishi; Nobuhiko Shinkura
Journal:  Breast Cancer       Date:  2015-03-31       Impact factor: 4.239

3.  Apocrine metaplasia: mammographic and sonographic appearances.

Authors:  J K Warner; D Kumar; W A Berg
Journal:  AJR Am J Roentgenol       Date:  1998-05       Impact factor: 3.959

Review 4.  Cystic breast masses and the ACRIN 6666 experience.

Authors:  Wendie A Berg; Alan G Sechtin; Helga Marques; Zheng Zhang
Journal:  Radiol Clin North Am       Date:  2010-09       Impact factor: 2.303

5.  Quantitative Maximum Shear-Wave Stiffness of Breast Masses as a Predictor of Histopathologic Severity.

Authors:  Wendie A Berg; Ellen B Mendelson; David O Cosgrove; Caroline J Doré; Joel Gay; Jean-Pierre Henry; Claude Cohen-Bacrie
Journal:  AJR Am J Roentgenol       Date:  2015-08       Impact factor: 3.959

6.  Clustered Microcysts at Breast US: Outcomes and Updates for Appropriate Management Recommendations.

Authors:  Alyssa R Goldbach; Catherine M Tuite; Eric Ross
Journal:  Radiology       Date:  2020-02-18       Impact factor: 11.105

7.  Multiple bilateral circumscribed masses at screening breast US: consider annual follow-up.

Authors:  Wendie A Berg; Zheng Zhang; Jean B Cormack; Ellen B Mendelson
Journal:  Radiology       Date:  2013-04-24       Impact factor: 11.105

8.  Probably benign lesions at screening breast US in a population with elevated risk: prevalence and rate of malignancy in the ACRIN 6666 trial.

Authors:  Richard G Barr; Zheng Zhang; Jean B Cormack; Ellen B Mendelson; Wendie A Berg
Journal:  Radiology       Date:  2013-10-28       Impact factor: 11.105

9.  Contrast Enhanced Digital Mammography (CEDM) Helps to Safely Reduce Benign Breast Biopsies for Low to Moderately Suspicious Soft Tissue Lesions.

Authors:  Margarita L Zuley; Andriy I Bandos; Gordon S Abrams; Marie A Ganott; Terri-Ann Gizienski; Christiane M Hakim; Amy E Kelly; Bronwyn E Nair; Jules H Sumkin; Uzma Waheed; David Gur
Journal:  Acad Radiol       Date:  2019-09-05       Impact factor: 3.173
  9 in total
  4 in total

Review 1.  BI-RADS 3 on Screening Breast Ultrasound: What Is It and What Is the Appropriate Management?

Authors:  Wendie A Berg
Journal:  J Breast Imaging       Date:  2021-08-15

2.  Dual-Intended Deep Learning Model for Breast Cancer Diagnosis in Ultrasound Imaging.

Authors:  Nicolle Vigil; Madeline Barry; Arya Amini; Moulay Akhloufi; Xavier P V Maldague; Lan Ma; Lei Ren; Bardia Yousefi
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

3.  Collagen fiber features and COL1A1: are they associated with elastic parameters in breast lesions, and can COL1A1 predict axillary lymph node metastasis?

Authors:  Ying Jiang; Bo Wang; Jun Kang Li; Shi Yu Li; Rui Lan Niu; Nai Qin Fu; Jiao Jiao Zheng; Gang Liu; Zhi Li Wang
Journal:  BMC Cancer       Date:  2022-09-21       Impact factor: 4.638

4.  A Score to Predict the Malignancy of a Breast Lesion Based on Different Contrast Enhancement Patterns in Contrast-Enhanced Spectral Mammography.

Authors:  Luca Nicosia; Anna Carla Bozzini; Simone Palma; Marta Montesano; Filippo Pesapane; Federica Ferrari; Valeria Dominelli; Anna Rotili; Lorenza Meneghetti; Samuele Frassoni; Vincenzo Bagnardi; Claudia Sangalli; Enrico Cassano
Journal:  Cancers (Basel)       Date:  2022-09-05       Impact factor: 6.575
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.